Safe Orthopaedics SA (EPA:ALSAF)
France flag France · Delayed Price · Currency is EUR
0.6400
0.00 (0.00%)
Jun 30, 2026, 5:18 PM CET

Safe Orthopaedics Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5.365.045.815.864.55
Revenue Growth
6.41%-13.24%-0.87%28.81%10.68%
Cost of Revenue
1.742.391.491.931.97
Gross Profit
3.622.654.323.932.58
Selling, General & Admin
6.417.957.869.289.43
Depreciation & Amortization Expenses
0.210.82.880.910.87
Other Operating Expenses
0.97-4.141.56-0.3-0.14
Total Operating Expenses
7.594.6112.39.8910.16
Operating Income
-3.97-1.96-7.98-5.96-7.58
Interest Expense
-0.51-2,122---0.59
Other Non-Operating Income (Expense)
0.02259.64-263.34-11.46
Total Non-Operating Income (Expense)
-0.49-1,862-263.34-10.87
Pretax Income
-4.46-1,864-271.32-6.97-6.71
Provision for Income Taxes
0.03-65.2165.8700
Net Income
-4.67-1,929-205.44-6.97-6.71
Net Income to Common
-4.67-1,929-205.44-6.97-6.71
Net Income Growth
-----
Shares Outstanding (Basic)
0-2--
Shares Outstanding (Diluted)
30-3--
Shares Change
-----
EPS (Basic)
-0.02--100.00--
EPS (Diluted)
-0.02--100.00--
EPS Growth
-----
Free Cash Flow
-2.15-3.3764.69-6.33-8.22
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.07-23.86--
Gross Margin
67.52%52.57%74.41%67.00%56.73%
Operating Margin
-73.94%-38.82%-137.31%-101.72%-166.64%
Profit Margin
-87.14%-38272.60%-3536.04%-118.84%-147.45%
FCF Margin
-40.14%-66.75%1113.37%-107.95%-180.57%
EBITDA
-2.49-0.83-3.66-5-6.71
EBITDA Margin
-46.33%-16.48%-62.94%-85.36%-147.54%
EBIT
-3.97-1.96-7.98-5.96-7.58
EBIT Margin
-73.94%-38.82%-137.31%-101.72%-166.64%
Effective Tax Rate
-0.70%3.50%-24.28%-0.01%0.00%